Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic (Q37617538)
scientific article published on 14 October 2009
Language:
Current Data About Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic
(P31) (Q13442814)
(P248)
(P698) 19840150
(P813) Monday, August 21, 2017

(Q815382)

(P50) (Q37840795)
(P1932) L Citrome
(P1545) 1

(P304) 1762-1784
(P248)
(P698) 19840150
(P813) Monday, August 21, 2017

(P407) (Q1860)

(P433) 12
(P248)
(P698) 19840150
(P813) Monday, August 21, 2017

(P478) 63
(P248)
(P698) 19840150
(P813) Monday, August 21, 2017

(P577) Wednesday, October 14, 2009
(P248)
(P698) 19840150
(P813) Monday, August 21, 2017

(P921) (Q41112)

(Q131755)
(P887)

(P1433) (Q15758177)
(P248)
(P698) 19840150
(P813) Monday, August 21, 2017

(P1476) "Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic" (language: en)
(P248)
(P698) 19840150
(P813) Monday, August 21, 2017

(P2860) (Q46976669)
(P248)
(P854) https://api.crossref.org/works/10.1111%2FJ.1742-1241.2009.02228.X
(P813) Sunday, January 21, 2018

(P13046) (Q7318358)
(P248)

other details
description scientific article published on 14 October 2009

External Links
(P356) 10.1111/J.1742-1241.2009.02228.X
(P698) 19840150
(P5875) 38021259